{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:42:52Z","timestamp":1792078972054,"version":"4.4.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3714,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>\n                                 <jats:bold>Although the natural history of autoimmune hepatitis (AIH) has been characterized, little is known about patients who present asymptomatically. Consequently, whether they require immunosuppressive therapy with its associated complications is unclear. To compare the natural history of asymptomatic AIH with symptomatic AIH, a large cohort of patients from a single center was examined. All patients with a clinical diagnosis of AIH were reassessed using the revised criteria of the International Autoimmune Hepatitis Group. Liver histology, response to therapy, and survival were assessed. Patients asymptomatic at presentation (n = 31) had lower serum aminotransferase, bilirubin, and immunoglobulin G (IgG) values at baseline. Half of the asymptomatic patients received no therapy, and their survival was no different from that of the total cohort. Ten-year survival was 80.0% (62.5%-97.5%) in the asymptomatic group and 83.8% (75.1%-92.6%) in the symptomatic patients (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= NS). Survival to liver-related endpoints at 10 years was similar in both groups: 89.5% (75.7%-100%) asymptomatic and 83.8% (75.1%-92.6%) symptomatic patients (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= NS). Patients with cirrhosis at baseline had poorer 10-year survival (61.9% [CI 44.9%-78.9%]) than those without cirrhosis at presentation (94.0% [CI 87.4%-100%]) (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= .003) regardless of whether they presented with symptoms or whether they received immunosuppressive therapy.<\/jats:bold>\n                                 <jats:underline>In conclusion<\/jats:underline>\n                                 <jats:bold>, patients with AIH who are asymptomatic at presentation have a good prognosis and may not require immunosuppressive therapy. Cirrhosis on initial liver biopsy portends a poor prognosis in all patients with AIH. (Hepatology 2005.)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.20732","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T20:18:37Z","timestamp":1118693917000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":299,"title":["Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *"],"prefix":"10.1097","volume":"42","author":[{"given":"Jordan J.","family":"Feld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Arenovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria A.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Wanless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"Heathcote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20250207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040641","article-title":"Natural history, clinical features, and treatment of autoimmune hepatitis.","volume":"4","author":"Czaja","year":"1980","journal-title":"Semin Liver Dis"},{"key":"R2-11-20250207","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"R3-11-20250207","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"R4-11-20250207","first-page":"1735","article-title":"Controlled trial of prednisone and azathioprine in chronic active hepatitis.","volume":"1","author":"MurrayLyon","year":"1973","journal-title":"Lancet"},{"key":"R5-11-20250207","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.1840080414","article-title":"Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.","volume":"8","author":"Stellon","year":"1988","journal-title":"Hepatology"},{"key":"R6-11-20250207","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/0016-5085(89)91701-0","article-title":"Prognosis of steroid treatment in HBsAg negative chronic active hepatitis in postmenopausal women.","volume":"97","author":"Wang","year":"1989","journal-title":"Gastroenterology"},{"key":"R7-11-20250207","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for longterm maintenance of remission in autoimmune hepatitis.","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"key":"R8-11-20250207","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R9-11-20250207","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis.","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"R10-11-20250207","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0002-9343(70)90049-5","article-title":"Active chronic hepatitis.","volume":"48","author":"Mistilis","year":"1970","journal-title":"Am J Med"},{"key":"R11-11-20250207","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroidtreated severe autoimmune chronic active hepatitis.","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"key":"R12-11-20250207","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with an acute presentation.","volume":"21","author":"Nikias","year":"1994","journal-title":"J Hepatol"},{"key":"R14-11-20250207","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF01076196","article-title":"Severe chronic active liver disease: prognostic significance of initial morphologic patterns.","volume":"22","author":"Schalm","year":"1977","journal-title":"Am J Dig Dis"},{"key":"R15-11-20250207","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/gut.19.6.510","article-title":"Longterm followup of chronic active hepatitis of moderate severity.","volume":"19","author":"Degroote","year":"1978","journal-title":"Gut"},{"key":"R16-11-20250207","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients.","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R17-11-20250207","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0016-5085(19)33990-3","article-title":"Classification and treatment of chronic active liver disease.","volume":"55","author":"Geal","year":"1968","journal-title":"Gastroenterology"},{"key":"R18-11-20250207","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"R19-11-20250207","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis.","volume":"127","author":"Dufour","year":"1997","journal-title":"Ann Intern Med"},{"key":"R20-11-20250207","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.20235","article-title":"Progressive fibrosis during corticosteroid therapy in autoimmune hepatitis.","volume":"39","author":"Czaja","year":"2004","journal-title":"Hepatology"},{"key":"R21-11-20250207","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0002-9343(61)90090-0","article-title":"Chronic liver disease in young people: clinical features and course in thirtythree patients.","volume":"30","author":"Willcox","year":"1961","journal-title":"Am J Med"},{"key":"R22-11-20250207","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.4.4.378","article-title":"Active juvenile cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy.","volume":"4","author":"Read","year":"1963","journal-title":"Gut"},{"key":"R23-11-20250207","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-9343(69)90169-7","article-title":"Longterm results of therapy in patients with chronic liver disease associated with hypergammaglobulinemia.","volume":"47","author":"Page","year":"1969","journal-title":"Am J Med"},{"key":"R24-11-20250207","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0016-5085(84)90186-0","article-title":"Development and prognosis of histologic cirrhosis in corticosteroidtreated HBsAgnegative chronic active hepatitis.","volume":"87","author":"Davis","year":"1984","journal-title":"Gastroenterology"},{"key":"R25-11-20250207","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20732","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200507000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:03:18Z","timestamp":1738944198000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200507000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20732","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}